| 000 | 017360000a22003490004500 | ||
|---|---|---|---|
| 003 | EG-GICUC | ||
| 005 | 20250223030140.0 | ||
| 008 | 061216s2005 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC |
||
| 041 | 0 | _aEng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.08.03.Ph.D.2005.Af.A. | ||
| 100 | 0 | _aAfaf Osman Mohamed Osman | |
| 245 | 1 | 0 |
_aAnalytical study on certain anti - ulcer drugs / _cAfaf Osman Mohamed Osman ; Supervised Mohamed Fayez Eltarras , Mohamed Galal Elbardicy , Zeinab Abd El Aziz Elsherif |
| 246 | 1 | 5 | _aدراسة تحليلية لبعض الادوية المضادة للقرحة |
| 260 |
_aCairo : _bAfaf Osman Mohamed Osman , _c2005 |
||
| 300 |
_a202P : _bcharts ; _c30cm |
||
| 502 | _aThesis (PH.D.) - Cairo University - Faculty Of Pharmacy - Department Of Analytical Chemistry | ||
| 520 | _aThe term acid - peptic disorders encompasses a variety of relatively specific medical conditions in which injury by gastric acid (acid activated pepsin) is thought to play an important role These disorders include gastroesophageal reflux disease , benignpepticulcers of the stomach and duodenum , ulcers secondary to the use of conventional non - steroidal anti - inflammatory drugs and ulcers due to the rare Zollinger - Ellison syndrome (1) | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAcid - peptic | |
| 653 | 4 | _aCertain Anti - Ulcer Drugs | |
| 653 | 4 | _agastroesophageal | |
| 700 | 0 |
_aMohamed Fayez Eltarras , _eSupervisor |
|
| 700 | 0 |
_aMohamed Galal Elbardicy , _eSupervisor |
|
| 700 | 0 |
_aZeinab Abd El Aziz Elsherif , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aAmira _eCataloger |
||
| 905 |
_aEsam _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c28590 _d28590 |
||